Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 13

Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice

Total article views   HTML views PDF downloads Totals
8,532 Dovepress* 7,257+ 1,402 8,659
PubMed Central* 1,275 288 1,563
Totals 8,532 1,690 10,222
*Since 17 March 2020
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar